Chemoinformaics analysis of 5-CAFFEOYL-SHIKIMIC-ACID
| Molecular Weight | 360.359 | nRot | 4 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 17 |
| Exact Molecular Weight | 360.142 | nRing | 3 |
| Solubility: LogS | -0.668 | nHRing | 2 |
| Solubility: LogP | -0.745 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 49.941 |
| nHD | 5 | BPOL | 30.153 |
| QED | 0.417 |
| Synth | 4.597 |
| Natural Product Likeliness | 2.858 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.017 |
| HIA | 0.939 |
| CACO-2 | -6.054 |
| MDCK | 0.00015112 |
| BBB | 0.659 |
| PPB | 0.218512 |
| VDSS | 0.293 |
| FU | 0.576754 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.044 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.173 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.124 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.069 |
| CL | 1.612 |
| T12 | 0.559 |
| hERG | 0.029 |
| Ames | 0.051 |
| ROA | 0.23 |
| SkinSen | 0.029 |
| Carcinogencity | 0.922 |
| EI | 0.008 |
| Respiratory | 0.202 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.796793 |